Assessment of Functional Capacity of Immune System in Patients with Multiple Sclerosis using QuantiFERON Monitor

Table 3

Pairwise comparison of the QuantiFERON Monitor test results.

Groups	diff	lwr	upr	Effect size (P-value)
Healthy controls vs. progressive MS	−0.6495209	−1.1511570	−0.147884809	0.0070598
Healthy controls vs. MS treated with fingolimod	−0.5341525	−1.0624314	−0.005873529	0.0468285
Progressive MS vs. MS treated with fingolimod	0.1153684	−0.3996581	0.630394952	0.8576530

Note: This table shows mean differences between groups (diff) and 95% confidence interval estimates (lwr = lower, upr = upper) for average differences. Each P-value, which represents the result of a pairwise parametric testing using t-test, is reported after Tukey correction for the false discovery rate.